Sort by
Keyphrases
BCP-ALL
85%
Paediatric B-cell Precursor Acute Lymphoblastic Leukaemia
31%
TCF3-PBX1
30%
Leukemic Cells
29%
Primary B Cells
28%
Mesenchymal Stromal Cells
27%
Acute Lymphoblastic Leukemia Cells
27%
Cell Tumor
25%
Aberrations
25%
Pathway mutation
25%
RAS Pathway
25%
Janus Kinase 2 (JAK2)
25%
Tyrosine Kinase Inhibitor Resistance
23%
Kinase Domain mutations
23%
Secondary Lesions
23%
3D Live Imaging
23%
Cell Behavior
23%
Engineered T Cells
23%
Imaging Platform
23%
Tumor Response
23%
Behavioral Response
23%
Cdx Genes
23%
Ibrutinib
23%
Childhood B-cell Precursor Acute Lymphoblastic Leukemia
23%
Bone Marrow Cells
23%
Treatment Adaptation
23%
Predictive Biomarker
23%
Bone Marrow
23%
Effective Compounds
23%
Mesenchymal Stroma
23%
Fibroblast Growth Factor Receptor 1 (FGFR1)
23%
Evolutionarily Conserved
23%
Intrachromosomal Amplification of Chromosome 21 (iAMP21)
23%
Signal Transduction Inhibitors
23%
Acute Lymphoblastic Leukemia
23%
Interferon-β (IFN-β)
23%
BCR-ABL1
16%
Subclonal mutations
16%
Supporting Cells
16%
BCR-ABL1-like
16%
Immune Cells
15%
JAK Inhibitors
13%
Bother
13%
Newly Diagnosed
12%
Hindbrain
11%
Tumor
11%
Primordia
11%
Mouse Embryo
11%
Truncation
11%
Trunk
11%
Biochemistry, Genetics and Molecular Biology
Precursor
77%
B Cell
77%
Janus Kinase
25%
Tyrosine Kinase Inhibitor
23%
Kinase
23%
Phosphotransferase
23%
Chromosome 21
23%
Cell Function
23%
T Cell
23%
Cdx
23%
Interferon
23%
Coculture
23%
Immunocompetent Cell
19%
Trametinib
13%
Imatinib
13%
Intravenous Immunoglobulin
11%
Stromal Cell
11%
Janus Kinase Inhibitor
9%
SH2B3
8%
CRLF2
7%
IKZF1
6%
PAX5
6%
Ruxolitinib
6%
Dynamics
5%
Cell Culture
5%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Precursor
81%
B Cell
81%
Janus Kinase
25%
Chromosome 21
23%
Ibrutinib
23%
Stroma
23%
Interferon
23%
Mesenchymal Stem Cell
22%
Leukemia Cell
22%
Janus Kinase Inhibitor
9%
Chemokine
7%
Bone Marrow Microenvironment
7%
Leukemia
6%
Ruxolitinib
6%
Placebo
5%
In Vitro
5%
Pediatrics
5%
Chondrocyte
5%
Osteocyte
5%
Cell Contact
5%
Fibroblast
5%
Adipocyte
5%